FMP
Orgenesis Inc.
ORGS
NASDAQ
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
0.5 USD
-0.0129 (-2.58%)
About
ceo
Ms. Vered Caplan M.Sc.
sector
Healthcare
industry
Biotechnology
website
https://www.orgenesis.com
exchange
NASDAQ
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 201...
CIK
0001460602
ISIN
US68619K2042
CUSIP
68619K204
Address
20271 Goldenrod Lane
Phone
480 659 6404
Country
US
Employee
146
IPO Date
Mar 13, 2012
Summary
CIK
0001460602
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
68619K204
ISIN
US68619K2042
Country
US
Price
0.5
Beta
1.1
Volume Avg.
241.7k
Market Cap
17.17M
Shares
-
52-Week
0.25-1.5
DCF
-0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.26
P/B
-
Website
https://www.orgenesis.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ORGS News
It looks like there's no news available.
